0EAP.L - Euroapi S.A.
| Previous close | 16.23 |
| Open | 15.55 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 16.49 - 16.53 |
| 52-week range | 16.49 - 16.53 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireEUROAPI: Combined General Meeting of May 11, 2023
PARIS, May 11, 2023--Regulatory News: The Combined General Shareholders’ Meeting of EUROAPI (Paris:EAPI) was held on May 11, 2023 in Paris, under the chairwomanship of Viviane Monges, and was attended by all directors. All resolutions put forth to a vote were adopted by the shareholders.
Business WireEUROAPI’s Board of Directors Proposes Géraldine Leveau as Director
PARIS, May 10, 2023--Regulatory News: The Board of Directors of EUROAPI (Paris:EAPI) proposes the ratification of the appointment by co-optation of a new director, Géraldine Leveau, as of May 10, 2023, replacing Jean-Christophe Dantonel, who resigned from his directorship. Her appointment will be proposed to ratification at the Annual General Meeting approving the financial statements as of December 31, 2023.
Business WireEUROAPI and Novéal sign CDMO agreement to advance cosmetic projects
PARIS, May 09, 2023--Regulatory News: EUROAPI announces today the implementation of an initial 4-year manufacturing agreement with Novéal, an integral part of the L’Oréal Group with a focus on developing eco-responsible processes and guaranteeing exclusive, high-performance ingredients to sustainably meet the beauty needs of consumers around the world.
Business WireEUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document
PARIS, April 26, 2023--Regulatory News: EUROAPI (Paris:EAPI) announces the publication of the first amendment to its 2022 Universal Registration Document, approved by the French Autorité des marchés financiers (AMF) on April 13, 2023, under number R.23-009. This Amendment has been approved by the AMF on April 25, 2023, under number R. 23-015.
Business WireEUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report
PARIS, April 14, 2023--Regulatory News: EUROAPI (Paris:EAPI) announces the publication of its 2022 Universal Registration Document, approved by the French Autorité des marchés financiers (AMF) on April 13, 2023, under number R.23-009.
Business WireEUROAPI: Full-Year 2022 Results
PARIS, March 08, 2023--Regulatory News: EUROAPI (Paris:EAPI):
Business WireEUROAPI: Progressive restart of prostaglandin production at Budapest site
PARIS, January 31, 2023--Regulatory News: EUROAPI (Paris:EAPI) progressively restarted prostaglandin production at its Budapest site on January 19.
Business WireEUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director
PARIS, January 11, 2023--Regulatory News: The Board of Directors of EUROAPI (Paris:EAPI) proposes the ratification of the appointment by co-optation of a new independent director, Mattias Perjos, as of January 11, 2023. Corinne Le Goff, after serving as an independent member on the Board of Directors since May 6, 2022, has resigned from her directorship as of January 11, 2023. Corinne Le Goff has been appointed as President and Chief Executive Officer of Imunon.
Business WireVitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France
PARIS, January 09, 2023--Regulatory News: EUROAPI (Paris:EAPI) announces that its Board of Directors has approved a €40 million investment for the implementation of a new production technology dedicated to vitamin B12 at its site in Saint-Aubin-lès-Elbeuf (Seine-Maritime, France). The project should enable EUROAPI to increase its manufacturing capacity by 2025 while reducing its environmental footprint. This investment benefits from a total financial support of €7.9 million, from the French Gove
Business WireEUROAPI Updates Its 2022 Financial Guidance
PARIS, December 07, 2022--Regulatory News: In the context of a temporary suspension of some of its production activities at its Budapest site, EUROAPI (Paris:EAPI) today provides an update on its financial guidance for 2022.
Business WireEUROAPI to Reach 500 kg Peptide and Oligonucleotide Capacity Per Year in Frankfurt by 2025
PARIS, October 31, 2022--Regulatory News: EUROAPI (Paris:EAPI) announces an initial €18 million investment for the installation of new state-of-the-art manufacturing equipment at its Frankfurt site. With this project, EUROAPI expects to meet the growing Contract Development and Manufacturing Organization (CDMO) demand for peptides and oligonucleotides. It will bolster the company’s German operations and reinforce EUROAPI’s commitment to advancing innovation in differentiated segments of active p
Business WireEUROAPI: Availability of 2022 Half-Year Financial Report
PARIS, September 01, 2022--Regulatory News: EUROAPI (Paris:EAPI) posted today its 2022 Condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2022. This document is available for consultation and downloading on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports.
Business WireEUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed
PARIS, September 01, 2022--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005650/en/
Business WireEUROAPI Announces the Success of Its First Global Employee Share Plan "EUROAPI Action 2022"
PARIS, July 22, 2022--Regulatory News: EUROAPI (Paris:EAPI) announces the success of its first employee share plan entitled "EUROAPI Action 2022", to which more than 67% eligible employees of the Group1 subscribed. This transaction, which was open from June 10 to June 24, 2022, in 7 countries, was designed to foster employees’ ownership and more closely associate them to the Group’s success and long-term development.
Business WireESG: EUROAPI Moves Forward With Its Carbon Reduction Ambition and Invests to Build a State-of-the-Art Biomass Boiler in France
PARIS, July 21, 2022--Regulatory News: EUROAPI (Paris:EAPI) announces the initiation of a €24 million investment for the construction of a state-of-the-art biomass boiler at its Saint-Aubin-lès-Elbeuf (Seine-Maritime, France) site that is planned to be activated in 2025. This investment should enable EUROAPI to support the site’s vitamin B12 production capacity increase program, reduce its CO2 emissions by almost 76% in 2026, compared to 2020 and support the Group’s strategy towards greater ener
- Business Wire
Availability of EUROAPI’s 2021 Half-Year Results
PARIS, July 01, 2022--Regulatory News: EUROAPI (Paris:EAPI) announces that, ahead of the publication of its 2022 half-yearly financial report on September 1st, 2022, it has made available financial information relating to the first half of 2021, including its historical half-year income statement and restated half-year adjusted performance measures including certain reclassifications within net sales disclosures for the period for comparability purposes with 2022. The Company has also included t
Business WireEUROAPI joins the SBF 120 and CAC Mid 60 indices
PARIS, June 09, 2022--Regulatory News: EUROAPI (Paris:EAPI) announces that it is included in the SBF 120 index and has now joined the CAC Mid 60 index, following the recent quarterly review of Euronext Paris Indices Committee.